Research takes aim at hypertrophic cardiomyopathy

08/27/2013 | GenomeWeb Daily News (free registration)

The National Heart, Lung, and Blood Institute has granted $14.4 million for the study of hypertrophic cardiomyopathy in an effort to identify the highest-risk patients. The University of Virginia School of Medicine and the University of Oxford will lead the effort, which will examine imaging, genetic and other predictive tools as well as demographics and clinical variables.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD